Article

Retinal assessment made easy by digital imaging

Wakeforest, NC-Digital Healthcare Inc. has received FDA approval to pre-market its retinal risk assessment system (Retasure) and its iP technology platform.

Wakeforest, NC-Digital Healthcare Inc. has received FDA approval to pre-market its retinal risk assessment system (Retasure) and its iP technology platform.

Primary-care physicians now can capture digital images of diabetic patients' retinas in a non-invasive procedure. The digital images are transmitted over a secure, HIPPA-compliant network to a board-certified ophthalmologist at an accredited reading center for examination and assessment.

Seven major contracts with primary diabetes care and ophthalmology providers have already been announced, and general availability throughout the United States is being planned.

This system is unique because it can be operated by non-clinicians; it's non-invasive and requires no dilation; it obtains high-quality digital images of the retina; it returns results quickly to primary-care physicians; and it encourages patient compliance for regular retinal assessment, according to Digital Healthcare.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
(Image credit: Ophthalmology Times) NeuroOp Guru: Cranial nerve six palsy with chemosis is a critical clue to cavernous carotid fistula
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
© 2025 MJH Life Sciences

All rights reserved.